US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 27.510
  • +0.490+1.81%
Close Mar 28 16:00 ET
  • 28.000
  • +0.490+1.78%
Post 19:34 ET
2.64BMarket Cap-5075P/E (TTM)

Intellia Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-30.40%36.28M
-114.12%-1.92M
-9.60%11.99M
-3.11%13.59M
12.03%12.61M
57.69%52.12M
5.59%13.57M
84.15%13.27M
114.20%14.03M
74.58%11.25M
Operating revenue
-30.40%36.28M
-114.12%-1.92M
-9.60%11.99M
-3.11%13.59M
12.03%12.61M
57.69%52.12M
5.59%13.57M
84.15%13.27M
114.20%14.03M
74.58%11.25M
Cost of revenue
Gross profit
Operating expense
8.09%551.57M
11.58%137.98M
20.46%143.1M
29.91%145.93M
-19.89%124.56M
69.58%510.29M
32.58%123.66M
50.00%118.8M
48.65%112.33M
194.11%155.5M
Selling and administrative expenses
29.00%116.5M
22.72%28.99M
32.77%29.4M
38.50%30.65M
22.52%27.45M
27.02%90.31M
6.87%23.63M
18.35%22.15M
32.66%22.13M
64.80%22.4M
-General and administrative expense
29.00%116.5M
22.72%28.99M
32.77%29.4M
38.50%30.65M
22.52%27.45M
27.02%90.31M
6.87%23.63M
18.35%22.15M
32.66%22.13M
64.80%22.4M
Research and development costs
3.59%435.07M
8.94%108.98M
17.64%113.7M
27.80%115.28M
-27.03%97.12M
82.75%419.98M
40.57%100.03M
59.79%96.65M
53.18%90.2M
238.87%133.1M
Operating profit
-12.47%-515.29M
-27.07%-139.89M
-24.24%-131.11M
-34.62%-132.33M
22.38%-111.96M
-71.05%-458.16M
-36.90%-110.09M
-46.58%-105.53M
-42.43%-98.3M
-210.71%-144.25M
Net non-operating interest income expense
483.38%49.83M
132.70%12.46M
555.01%12.74M
1,699.86%12.65M
2,118.52%11.98M
565.78%8.54M
964.41%5.35M
457.31%1.95M
233.18%703K
145.45%540K
Non-operating interest income
483.38%49.83M
132.70%12.46M
555.01%12.74M
1,699.86%12.65M
2,118.52%11.98M
565.78%8.54M
964.41%5.35M
457.31%1.95M
233.18%703K
145.45%540K
Other net income (expense)
35.95%-15.73M
45.49%-4.73M
60.01%-3.86M
-29.87%-4M
0.57%-3.15M
-1,753.89%-24.56M
-8.67M
-9.64M
-3.08M
-3.17M
Earnings from equity interest
-41.10%-15.63M
-45.57%-4.73M
-110.31%-3.86M
-23.00%-4M
-11.04%-3.05M
-736.15%-11.08M
-145.13%-3.25M
---1.83M
---3.25M
---2.75M
Special income (charges)
99.26%-100K
--0
--0
--0
76.25%-100K
---13.49M
---5.43M
---7.81M
--172K
---421K
-Less:Restructuring and merger&acquisition
-99.26%100K
--0
--0
--0
-76.25%100K
--13.49M
--5.43M
--7.81M
---172K
--421K
Income before tax
-1.48%-481.19M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-77.01%-474.19M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
Income tax
Net income
-1.48%-481.19M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-77.01%-474.19M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
Net income continuous Operations
-1.48%-481.19M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-77.01%-474.19M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
Minority interest income
Net income attributable to the parent company
-1.48%-481.19M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-77.01%-474.19M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1.48%-481.19M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-77.01%-474.19M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
Basic earnings per share
12.01%-5.42
-4.29%-1.46
7.38%-1.38
-5.26%-1.4
40.31%-1.17
-62.96%-6.16
-28.44%-1.4
-53.61%-1.49
-31.68%-1.33
-184.06%-1.96
Diluted earnings per share
12.01%-5.42
-4.29%-1.46
7.38%-1.38
-5.26%-1.4
40.31%-1.17
-62.96%-6.16
-28.44%-1.4
-53.61%-1.49
-31.68%-1.33
-184.06%-1.96
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -30.40%36.28M-114.12%-1.92M-9.60%11.99M-3.11%13.59M12.03%12.61M57.69%52.12M5.59%13.57M84.15%13.27M114.20%14.03M74.58%11.25M
Operating revenue -30.40%36.28M-114.12%-1.92M-9.60%11.99M-3.11%13.59M12.03%12.61M57.69%52.12M5.59%13.57M84.15%13.27M114.20%14.03M74.58%11.25M
Cost of revenue
Gross profit
Operating expense 8.09%551.57M11.58%137.98M20.46%143.1M29.91%145.93M-19.89%124.56M69.58%510.29M32.58%123.66M50.00%118.8M48.65%112.33M194.11%155.5M
Selling and administrative expenses 29.00%116.5M22.72%28.99M32.77%29.4M38.50%30.65M22.52%27.45M27.02%90.31M6.87%23.63M18.35%22.15M32.66%22.13M64.80%22.4M
-General and administrative expense 29.00%116.5M22.72%28.99M32.77%29.4M38.50%30.65M22.52%27.45M27.02%90.31M6.87%23.63M18.35%22.15M32.66%22.13M64.80%22.4M
Research and development costs 3.59%435.07M8.94%108.98M17.64%113.7M27.80%115.28M-27.03%97.12M82.75%419.98M40.57%100.03M59.79%96.65M53.18%90.2M238.87%133.1M
Operating profit -12.47%-515.29M-27.07%-139.89M-24.24%-131.11M-34.62%-132.33M22.38%-111.96M-71.05%-458.16M-36.90%-110.09M-46.58%-105.53M-42.43%-98.3M-210.71%-144.25M
Net non-operating interest income expense 483.38%49.83M132.70%12.46M555.01%12.74M1,699.86%12.65M2,118.52%11.98M565.78%8.54M964.41%5.35M457.31%1.95M233.18%703K145.45%540K
Non-operating interest income 483.38%49.83M132.70%12.46M555.01%12.74M1,699.86%12.65M2,118.52%11.98M565.78%8.54M964.41%5.35M457.31%1.95M233.18%703K145.45%540K
Other net income (expense) 35.95%-15.73M45.49%-4.73M60.01%-3.86M-29.87%-4M0.57%-3.15M-1,753.89%-24.56M-8.67M-9.64M-3.08M-3.17M
Earnings from equity interest -41.10%-15.63M-45.57%-4.73M-110.31%-3.86M-23.00%-4M-11.04%-3.05M-736.15%-11.08M-145.13%-3.25M---1.83M---3.25M---2.75M
Special income (charges) 99.26%-100K--0--0--076.25%-100K---13.49M---5.43M---7.81M--172K---421K
-Less:Restructuring and merger&acquisition -99.26%100K--0--0--0-76.25%100K--13.49M--5.43M--7.81M---172K--421K
Income before tax -1.48%-481.19M-16.54%-132.16M-7.94%-122.22M-22.85%-123.68M29.79%-103.13M-77.01%-474.19M-39.60%-113.41M-58.04%-113.23M-46.32%-100.68M-217.87%-146.87M
Income tax
Net income -1.48%-481.19M-16.54%-132.16M-7.94%-122.22M-22.85%-123.68M29.79%-103.13M-77.01%-474.19M-39.60%-113.41M-58.04%-113.23M-46.32%-100.68M-217.87%-146.87M
Net income continuous Operations -1.48%-481.19M-16.54%-132.16M-7.94%-122.22M-22.85%-123.68M29.79%-103.13M-77.01%-474.19M-39.60%-113.41M-58.04%-113.23M-46.32%-100.68M-217.87%-146.87M
Minority interest income
Net income attributable to the parent company -1.48%-481.19M-16.54%-132.16M-7.94%-122.22M-22.85%-123.68M29.79%-103.13M-77.01%-474.19M-39.60%-113.41M-58.04%-113.23M-46.32%-100.68M-217.87%-146.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1.48%-481.19M-16.54%-132.16M-7.94%-122.22M-22.85%-123.68M29.79%-103.13M-77.01%-474.19M-39.60%-113.41M-58.04%-113.23M-46.32%-100.68M-217.87%-146.87M
Basic earnings per share 12.01%-5.42-4.29%-1.467.38%-1.38-5.26%-1.440.31%-1.17-62.96%-6.16-28.44%-1.4-53.61%-1.49-31.68%-1.33-184.06%-1.96
Diluted earnings per share 12.01%-5.42-4.29%-1.467.38%-1.38-5.26%-1.440.31%-1.17-62.96%-6.16-28.44%-1.4-53.61%-1.49-31.68%-1.33-184.06%-1.96
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg